Mergers & Acquisitions

WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca’s Innovative Biologics Portfolio in China

WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca’s Innovative Biologics Portfolio in China PR Newswire SHANGHAI, Dec. 16, 2015 SHANGHAI , Dec. 16, 2015 /PRNewswire/ — WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca. […]

Mergers & Acquisitions

Bureau Veritas Consumer Products Services Acquires CERTEST, an Italian Laboratory Specialised in Leather and Luxury Goods

Bureau Veritas Consumer Products Services Acquires CERTEST, an Italian Laboratory Specialised in Leather and Luxury Goods PR Newswire HONG KONG, December 16, 2015 HONG KONG , December 16, 2015 /PRNewswire/ — ~ Expanding Bureau Veritas offering to the luxury market ~ Bureau Veritas Consumer Products Services (BVCPS) is pleased to announce the acquisition of CERTEST, an Italian leather and apparel laboratory located in Tuscany and specialised in the testing of luxury goods. This acquisition reinforces BVCPS footprint in Italy , home to the world’s most famous fashion designers and labels, and also a major manufacturing country for garments, footwear and leather goods. Founded in 2004 and located in the tannery district of Ponte A Egola in San Miniato, CERTEST has established a strong technical reputation in the leather and garment industry, working with an impressive portfolio of major brands in both the fashion and luxury markets […]

Stock Analysts

VMware (VMW) Cancels Virtustream Joint Venture with EMC

VMware, Inc. VMW has announced that it will not form Virtustream Cloud Services Business with EMC as announced this October. VMware gained a lot of attention in the past few months since its parent company EMC Corporation EMC announced its acquisition by Dell, the deadline for which is just around the corner now. […]

Stock Analysts

AES Corp (AES) Gifts Investors with 10% Dividend Increase

The AES Corporation AES announced that its board of directors has approved a 10% hike in its quarterly common stock dividend, bringing the annualized payout to 44 cents per share. The annual yield on the dividend is 4.9%. The raised dividend of 11 cents per share, up from the prior payment of 10 cents, will be effective from the first quarter of 2016 […]

Stock Analysts

Should Chubb Corporation (CB) be in Your Portfolio Now?

On Dec 15, Zacks Investment Research upgraded Chubb Corporation CB to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Chubb has been witnessing a rise in earnings estimates on the back of strong third-quarter 2015 results, rollout of complementary risk management services and approval of its merger with ACE Limited ACE […]

Stock Analysts

Is ICE Set to Benefit from Interactive Data Acquisition?

In order to strengthen its data and valuation capabilities globally, Intercontinental Exchange Group ICE has completed the acquisition of Interactive Data Corporation. The deal was announced in Oct 2015 and the company mentioned the receipt of regulatory approvals last week. Subsequent to closing of the acquisition, Interactive Data, which was a part of Silver Lake and Warburg Pincus has now become a wholly owned subsidiary of ICE. […]

Stock Analysts

Aduro’s CRS-207/GVAX Pancreas Gets Orphan Status in EU

Aduro BioTech, Inc. ’s ADRO shares gained 4.3% after the company announced that the European Medicines Agency has granted Orphan Drug designation to CRS-207 in combination with GVAX Pancreas for the treatment of patients with pancreatic cancer. The combination is currently being evaluated in comparison to chemotherapy in the phase IIb ECLIPSE study for the treatment of patients with metastatic pancreatic cancer […]

Stock Analysts

Bristol-Myers & UCLA Sign Immuno-Oncology Collaboration

Bristol-Myers Squibb Company BMY announced that it has entered into a collaboration agreement with UCLA under its Immuno-Oncology Rare Population Malignancy (I-O RPM) research program. The company will conduct a range of early-phase studies with the David Geffen School of Medicine at UCLA. Bristol-Myers is focused on expanding its immuno-oncology portfolio and is highly active on the deal signing/acquisition front […]

Stock Analysts

Akebia Up on Mitsubishi Tanabe Pharma Deal for Vadadustat

Akebia Therapeutics, Inc. AKBA gained 7.1% after the company announced that it has entered into a development and commercialization agreement with Mitsubishi Tanabe Pharma Corporation for its lead candidate, vadadustat (formerly AKB-6548), for the treatment of anemia related to chronic kidney disease (CKD) in Japan and certain other countries in Asia. […]

Stock Analysts

Defense Stock Roundup: Lockheed to Build PAC-3 Missiles, Boeing Boosts Dividend 20%

“You are next”: A warning for the leaders of Islamic State by President Obama, who has vowed to destroy the jihadists in Iraq and Syria, may not be all good for world peace, but should act as a major tailwind to the defense stocks. Obama has ramped up his operation against ISIS and spoke about his plans to knock out the group after taking months of criticism from Americans over his handling of the terror group. Despite optimism, volatility still exists in the defense share market with major companies ending in the red last week […]